Loading...
First-line cetuximab-based chemotherapies for patients with advanced or metastatic KRAS wild-type colorectal cancer
Colorectal cancer (CRC) is one of the most commonly occurring cancers worldwide. A burgeoning number of studies have demonstrated that the addition of cetuximab to another standard first-line regimen markedly improves the outcome of CRC treatment. However, at present, the efficacy and safety of cetu...
Na minha lista:
Udgivet i: | Mol Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
D.A. Spandidos
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4950727/ https://ncbi.nlm.nih.gov/pubmed/27446583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.938 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|